About The Study: In Chinese adults with obesity or overweight, once-weekly injection with tirzepatide 10 mg or 15 mg resulted in statistically significant and clinically meaningful weight reduction with an acceptable safety profile.
About The Study: In Chinese adults with obesity or overweight, once-weekly injection with tirzepatide 10 mg or 15 mg resulted in statistically significant and clinically meaningful weight reduction with an acceptable safety profile.
Corresponding Author: To contact the corresponding author, Xiaoying Li, M.D., email li.xiaoying@zshospital.sh.cn.
To access the embargoed study: Visit our For The Media website at this link
(doi:10.1001/jama.2024.9217)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time
Journal
JAMA
Cite Scienmag News
Daisy Hatcher. (May 31, 2024). Tirzepatide for weight reduction in Chinese adults with obesity. Scienmag. https://scienmag.com/tirzepatide-for-weight-reduction-in-chinese-adults-with-obesity/
Daisy Hatcher. "Tirzepatide for weight reduction in Chinese adults with obesity." Scienmag, 31 May 2024, https://scienmag.com/tirzepatide-for-weight-reduction-in-chinese-adults-with-obesity/. Accessed 5 September 2026.
Daisy Hatcher. "Tirzepatide for weight reduction in Chinese adults with obesity." Scienmag. May 31, 2024. https://scienmag.com/tirzepatide-for-weight-reduction-in-chinese-adults-with-obesity/
